See melanoma
from a new
perspective.
™
See more. Know more.
Clinically ambiguous PSLs pose a unique diagnostic challenge. Even with years of
clinical experience, subjective impressions sometimes don't provide enough information
for a clear biopsy decision. MelaFind® gives you objective data, for a different perspective
on clinically ambiguous PSLs and the most curable melanomas.
Examine Lesions Beneath the Surface of the Skin
. Works within your current protocols
. Multi-spectral technology helps
you differentiate clinically ambiguous
lesions from melanoma
. Enhances clinical decision making
. Ultra-high sensitivity with better
specificity than achievable by
visualization alone—with or
without a dermoscope
. Clinically-tested, non-invasive,
FDA-approved device
Important Safety Information
MelaFind® is intended to be used when a dermatologist chooses to obtain additional information for a
decision to biopsy, but MelaFind® should NOT be used to confirm a clinical diagnosis of melanoma. As with
all tools to provide additional information during skin exams, there is a risk that melanomas will be missed
and benign moles will be biopsied.
MelaFind® is indicated for use on clinically atypical cutaneous pigmented skin lesions with a diameter
between 2mm and 22mm that are accessible by MelaFind®, sufficiently pigmented (ie, not for use on nonpigmented or skin-colored lesions), that do not contain a scar or fibrosis consistent with previous trauma,
where the skin is intact (ie, non-ulcerated, non-bleeding lesions), that are
more than 1cm away from the eye, do not contain foreign matter, and are
not on special anatomic sites (ie, not for use on acral, palmar,
plantar, mucosal, or subungual areas).
4PVUI#VDLIPVU4Ut4VJUFt*SWJOHUPO
/:
www.melasciences.com
ª.&-"4DJFODFT
*OD..*3FW"
Learn more about MelaFind® at
melafind.com/newperspective